Login / Signup

Benefits and risks of Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis.

Kana HigashitaniKaoru Takase-MinegishiRyusuke YoshimiYohei KirinoNaoki HamadaHideto NagaiMaki HagiharaKenji MatsumotoHo NamkoongNobuyuki HoritaHideaki Nakajima
Published in: Modern rheumatology (2022)
HSCT is an effective treatment for SSc, but the optimal indications must be carefully determined by balancing the risks.
Keyphrases
  • systemic sclerosis
  • interstitial lung disease
  • human health
  • acute myeloid leukemia
  • rheumatoid arthritis
  • climate change